First Early Detection Of Diabetes

First Early Detection Of Diabetes


Are you at risk for type 2 diabetes? 

Different to any theoretical risk assessment (diabetes genes, family history, obesity, etc.), the measurement of our functional ß-cell dysfunction biomarker with a simple at home test shows patients who have begun to develop type 2 diabetes.  

Our test method is a typical Point-of-care test (POCT). POCT or bed-side testing is defined as medical testing at or near the site of patient care. These are simple medical blood tests, which can even be performed at home, such as urine test strips or blood test strips, usually with a visual read-out, similar to a pregnancy tests. These tests provide a qualitative "yes" or "no" answer, and a patient with a positive finding is advised to seek medical advise for further diagnosis and care.

Simple tests such as those found in medical examinations, urin test strip or blood test strip and even simple imaging such as with a portable ultrasound device. The question is: Is there a risk for my health? The answer is: yes or no.

Target population for our POCT test:

The test can be used to confirm or exclude diabetes development in patients with risk factors (e.g. obesity, family history if diabetes or cardiovascular disease etc.). It is simple, easy to perform, and can be performed by patients and health care providers. The potential market size includes theoretically the the entire US population (320 million subjects) with an additional 700 million potential customers in Central America and South America. About 20-25% of them have known diabetes or are in the process to develop the disease. The absolute potential market size increases by about 10-15% per year. Special customers are individuals or companies that are performing annual health checks for their employees including but not limited to airlines, public transportation companies, and the military forces.